We have studied recombinatorial events of the T cell receptor a and y chain genes in hematopoietic malignancies and related these to normal stages of lymphoid differentiation. T cell receptor a gene recombinatorial events were found in 91% of acute T cell lymphoblastic leukemia, 68% of non-T, non-B lymphoid precursor acute lymphoblastic leukemia (ALL) and 80% of mixed lineage acute leukemias. Mature B-lineage leukemias and acute nonlymphocytic leukemias retained the Tcell receptor a gene in the germline configuration. The incidence of T cell receptor 'y and was particularly high in CD10CD19+ non-T, non-B lymphoid precursor ALL. In lymphoid precursor ALL, T cell receptor a was frequently rearranged while T cell receptor y was in the germline configuration. This suggests that TCR a rearrangements may precede TCR y rearrangements in lymphoid ontogeny. In T-ALL, only concordant T cell receptor a and y rearrangements were observed. Several distinct rearrangements were defined using a panel of restriction enzymes. Most of the rearrangements observed in T-ALL represented joining events of Jb1 to upstream regions. In contrast, the majority of rearrangements in lymphoid precursor ALL most likely represented D-D or V-D rearrangements, which have been found to be early recombinatorial events of the TCR a locus. We next analyzed TCR a rearrangements in five CD3'TCR'y/5' ALL and cell lines. One T-ALL, which demonstrated a different staining pattern with monoclonal antibodies against the products of the TCR -y/S genes than the PEER cell line, rearranges Jb1 to a currently unidentified variable region.
Introduction
Leukemias are believed to represent clonal expansions of hematopoietic precursor cells arrested at varying stages of differentiation (1, 2) . They provide an opportunity to study clonal populations of lymphoid cells at different stages of differentiation at the molecular level. These studies have provided important insight into the frequency, hierarchy, and diversity of rearrangements ofmembers ofthe immunoglobulin supergene family. Recently, a fourth T cell receptor gene, TCRI 6 , has been identified (3) (4) (5) (6) (7) (8) . Its gene product is coexpressed as a heterodimer in conjunction with the TCR y chain on a subset of T lymphocytes with so far unknown function (3) (4) (5) (6) (7) (8) (9) . Since the genomic repertoire ofthe TCR y chain gene appears to be very limited (10) (11) (12) (13) (14) , the determination of the genomic diversity of the TCR 6 chain gene is of great importance for a better understanding of antigens that are potentially detected by the T cell receptor y/b chain. Due to its unique chromosomal localization within the TCR a locus, the TCR a locus must be deleted when a functional Va-Ja rearrangement occurs (3) (4) (5) (6) (15) (16) (17) (18) (19) (20) . Therefore, the TCR 6 locus may play a crucial role in early lymphoid ontogeny, and it may be helpful in elucidating the relationship of leukemic precursor cells to the T-and Blineages. Recently, a high incidence of TCR 6 rearrangements and deletions of 80-90% has been reported (21, 22) in B cell precursor ALL. In order to come to a better understanding of these issues, the TCR 6 and y gene rearrangements were studied in human lymphoid and myeloid malignancies and cell lines and questions of frequency and lineage association, hierarchy, and diversity of TCR a recombinatorial events were addressed.
Methods
Fresh leukemic cells and cell lines. Patient samples were selected according to availability and sufficient material. Samples included patients enrolled in the Children's Cancer Study Group (CCSG) whose bone marrow samples were sent for immunophenotyping to the reference laboratory at the University of Minnesota and local pediatric and adult patients at the University of Minnesota and affiliated hospitals. Mononuclear cells were isolated from leukemic peripheral blood or bone marrow containing > 80% leukemic blasts as described previously (23) (24) (25) . Leukemic cells and cell lines are listed in Table I based on immunophenotype and cytochemistry, as discussed later. The cell lines used in this study were established from patients with lymphoid, myeloid, and mixed lineage acute leukemias, as described elsewhere (23, 25) . The cell lines Molt 3, Molt 4, HPB-mlt, HSB-2, Nalm 6, HPB-null, ML-2, ML-3 were generous gifts from Dr. J. Minowada. ML-2 and ML-3 (cases 65, 66) are well described cell lines from the same patient with acute myelogenous leukemia. The RS4; 1 cell line (case 67) was established from a patient with ALL and displays the combination of lymphoid and monocytic characteristics in vitro as described in detail elsewhere (26) . The DU.528.4 (27) cell line was a kindly provided by J. Kurtzberg and M. S. Hershfield, Duke University, Durham, NC. Two EBV-transformed cell lines were established 1. Abbreviations used in this paper: AL, acute leukemia; ALL, acute lymphoblastic leukemia; ANLL, acute nonlymphoblastic leukemia; C, constant region; CLL, chronic lymphocytic leukemia; D, diversity element; J, joining region; LCL, lymphoblastoid cell lines; LP-ALL, lymphoid precursor acute lymphoblastic leukemia; PE, phycoerythrin; from B cells from a normal donor (FJO-LCL) and a patient post-bone marrow transplantation (TM-LCL), respectively.
MN-B3 (case 30) is a nonleukemic TCR -y/6 clone, established from the peripheral blood of a normal donor. Peripheral blood mononuclear cells were isolated as described and cultured in the presence of recombinant human IL-2 200 U/ml (AMGen Biochemicals, Thousand Oaks, CA) for 10 d. The cultured cells were sorted on a FACS IV (Becton, Dickinson & Co., Mountain View, CA) for the CD3+WT3 1-population and set up in bulk culture for additional 3 d in the presence of Identi-T 6 TCS1 (T-Cell Sciences, Cambridge, MA) and IL-2 200 U/ml. The cells were subsequently subcloned by limiting dilution in the presence of IL-2 and irradiated EBV-transformed lymphoblastoid feeder cells.
Cytochemistry. The acute nonlymphoblastic leukemias and cell lines were positive for at least one of the following myeloid lineage associated cytochemical stains: myeloperoxidase, nonspecific esterase, chloroacetate esterase, leukocyte alkaline phosphatase. All fresh acute lymphoid leukemias, T and B cell lineage cell lines were negative for myeloid lineage associated cytochemical stains and had lymphoid morphology.
Immunophenotyping. 39 , see note added in proof), J 6 I and part ofthe constant region of the TCR 6 gene (Fig. 1) .
Rearrangements of the TCR y gene were detected in Bam HI and Eco RI digests with a 1.6-kb Eco RI/Eco RI cDNA probe pTy 1 (40) kindly provided by R. Holcombe and J. Seidman, Harvard University, Boston, MA.
Results
Categories of TCR 6 gene status. The following categories of TCR 6 genotype were detected: Biallelic germline configuration when the Cb and the J6 1 bands had the expected intensity and no nongermline bands were detectable (G). Because no rigorous densitometry was done, the possibility of germline configuration on one allele and deletion of the complete TCR 6 locus (C6 and Jb 1) on the other allele can not always be Frequency andpatterns ofTCR 6 recombinatorial events in T-ALL and other leukemias. We first studied the frequency of TCR 6 recombinatorial events in T-ALL and other leukemias in order to evaluate lineage association. Only 9% of T-ALL were germline for one or both TCR 6 alleles, reflecting a high frequency of recombinatorial events. 61% had TCR 6 rearrangements and 30% biallelic deletions. In contrast to the T-ALL, all 15 mature B-lineage malignancies and all 16 ANLL retained the TCR 6 in germline configuration. TCR Further analysis ofthe pattern of recombinatorial events in T-ALL and lymphoid precursor ALL revealed marked differences between these two groups. The combination of monoallelic rearrangement and germline configuration of the second allele (R/G) prevailed in lymphoid precursor ALL (59% of the rearranged cases). This recombination pattern occurred in only 20% of the rearranged T-ALL. Biallelic deletions of the TCR 6 locus were observed in 33% of the T-ALL compared to only 13% of the lymphoid precursor ALL. Thus deletional events of the TCR 6 locus were by far more frequently seen in T-ALL than in lymphoid precursor ALL. These differences were also reflected in the analysis of individual alleles. In T-ALL, the majority of alleles (85%) underwent deletion (42.5%) or rearrangement (42.5%), whereas in lymphoid precursor ALL the majority of alleles (47%) remained in the germline configuration. The usage ofthe cDNA probe allowed to assess the status ofthe V61 region in those cases that showed biallelic deletions of the TCR 6 constant and joining regions. Whereas V6 1 was not deleted in any ofthe lymphoid precursor ALL, the majority of T-ALL with deletion of the TCR 6 joining and constant locus (64%) also deleted the V6 1. TCR 6 rearrangements in various stages of T-cell differentiation. We next addressed the question whether frequency and pattern of recombinatorial events in T-ALL were dependent on the stage of differentiation within the T-lineage. Three cases retained the TCR 6 gene in the germline configuration, all of which were at the earliest stage of differentiation (early thymocyte). In later stages of differentiation, the percentage of biallelic deletions ofthe TCR 6 locus increased. In the group of mature TCR a/, expressing T-lymphocytes all but one (case 28) deleted both TCR 6 alleles. The TCR y/6 expressing T-ALL rearranged one TCR 6 allele and had the second in a rearranged, deleted or in the germline configuration. Relationship of TCR 6 and y rearrangements. We next studied whether recombinatorial events of the TCR 6 locus occurred in concordance with TCR 7 rearrangements. These studies would allow us to determine whether TCR 6 and y genes are rearranged in a hierarchically ordered versus a stochastic pattern. In T-ALL, TCR y gene rearrangements were observed in 91% of the cases, and no discordant rearrangements between TCR y and TCR 6 were demonstrated. However, discordant rearrangements of the TCR 6 and y genes were observed in 32% (10/3 1) of the lymphoid precursor ALL. 9 of 10 underwent TCR 6 recombinatorial events ( Evaluation of the distribution of the different rearrangements in various groups of leukemias revealed that types 3 and 6 rearrangements were most frequently found in lymphoid precursor ALL and mixed lineage AL where they accounted for 92% of the rearrangements (Fig. 2) . In T-ALL, the 3.5-kb Eco RI rearrangement (type 8) was most frequently seen (seven cases) and accounted for 28% of the rearranged T-ALL-alleles.
The analysis of TCR 6 rearrangements with the restriction enzymes Xba I and Hind III were particularly instructive. The type 3 rearrangement was not rearranged with Xba I and the type 6 rearrangement was not rearranged with Xba I and Hind III. The restriction map of the TCR 6 locus (Fig. 1) locates the Xba I site between the J6 1 and the D62 regions and the Hind III site 5' of D62. Therefore, the type 3 rearrangement most likely represents a joining event of D62 to a 5' region, possibly Db 1 or a Va/6 region. However, recombinations of yet undefined regions 5' of Jb1 can not be ruled out. The type 6 rearrangement may represent the recombination of as yet undescribed regions 5' of D62. The other types of rearrangements described above, were all rearranged with both Hind III and Xba I, indicating that a D62-J6 1 join underwent further rearrangement to 5' regions, possibly Db 1 or Va/6 region.
Of particular interest is the 3.5-kb Eco RI rearrangement, which was observed in 7 T-ALL and not in other leukemias. This rearrangement has been shown to represent a functional V6I-J6 1 join in leukemic and nonleukemic TCR 7/6 expressing cell lines. Two CD3+TCR y' fresh T-ALL (cases 31 and 32) displayed the identical 3.5-kb Eco RI rearrangement. In addition, the 3.5-kb Eco RI rearrangement was observed in the nonleukemic T7/6 clone MN-B3, which was TCS-1+ TiyA-. 5 6 7 8 9 10 11 12 TYPES OF REARRANGEMENT Figure 2 . Distribution of distinct TCR 6 rearrangements, as defined in Table II , in T-ALL and other acute leukemias (LP-ALL, mixed lineage AL). 51 rearranged alleles were analyzed with Eco RI, Bam HI, Hind III, and Xba I.
T,y/6 (29) . In this leukemia, type 3 and 4 rearrangements were detected, while no 3.5-kb Eco RI rearrangement was observed. In Southern analysis, using the cDNA probe 0-240/38, the VA 1 region was not found to be rearranged but remained in the germline configuration. We therefore propose that a so far unidentified Vb region was functionally rearranged in this T-ALL. To the knowledge ofthe authors, this is the first report of a CD3+TCR'y/6 leukemia expressing a variable region different from VA 1.
Discussion TCR 6 recombinatorial events in hematopoitic cells. In this manuscript, we present results on recombinatorial events involving the TCR 6 and y loci in a series of 100 hematological 65 88 2 98GL
-"16kb (21, 22) in this group of leukemias. Furthermore, the frequency of TCR 6 rearrangements may be underestimated, because rearrangements of not yet described 5'joining regions, recombinations with the deletional acceptor site "6 Rec" (20) or V6-Db rearrangements can not be detected with the probes and the restriction enzymes used in this study (see Fig. 1 # genes (38, 44, 45) . Unfortunately, our numbers are too small to demonstrate statistically significant differences in the frequency of TCR a rearrangements between these two subgroups. Taken these results together, CDlIOCDl9+ ALL corearrange IgH and TCR genes with a surprisingly high frequency. These findings raise interesting questions as to which hematopoietic cell is the target cell for malignant transformation in CDlIOCDl9+ ALL. The pattern of recombinatorial events was different in T-ALL and lymphoid precursor ALL. Lymphoid precursor ALL tended to undergo recombinatorial events only on one allele, while in T-ALL biallelic recombinatorial events prevailed. These data are similar to the TCR y gene, where lymphoid precursor ALL predominantly display monoallelic and T-ALL biallelic rearrangements (24, (43) (44) (45) (46) 51) . Similarly to the lymphoid precursor ALL, TCR 6 recombinatorial events were frequently observed in mixed lineage AL. In contrast to the lymphoid precursor ALL, none of the mature B-lineage cell lines and malignancies rearranged the TCR a locus. These findings are consistent with previous reports on the low incidence of rearrangements of the TCR y and , genes in mature B-lineage cells (58, 59) . Our findings confirm the hypothesis that in the cases of mature B-cell lymphoma and B-CLL, a more mature and committed cell undergoes malignant transformation.
The analysis of the myeloid leukemias and cell lines revealed that all 16 cases studied retained the TCR a gene in the germline configuration. These findings are consistent with the previous results obtained by ourselves (24) and others (60) in acute nonlymphoblastic leukemias in which no TCR y and ,B or IgH rearrangements were present. These observations confirm the notion that only rare myeloid leukemias will undergo rearrangement of members of the immunoglobulin supergene family. However, a larger sample number may reveal a low percentage of TCR 6 rearrangements and deletions as has been shown for TCR y and ,B and the immunoglobulin heavy chain genes (61, 62 Hierarchy of TCR 6 and y rearrangements. We next analyzed the frequency and pattern of TCR a rearrangements at different stages of differentiation within the T-lineage. Of 33 T-lineage ALL and T-cell lines studied, only immature T-ALL expressing a phenotype of early thymocytes (31) retained the TCR 6 gene in the germline configuration. Although the TCR a gene is rearranged and transcribed very early in T-lineage ontogeny, these data may suggest that the commitment of a lymphoid precursor cell to the T-lineage may not require TCR a rearrangements. A lower incidence of rearrangements of the TCR y and , genes (24, 63, 64) has been previously reported in these early cells of the T-lineage. Recent studies in murine T-precursor clones showed that the TCR y and ( genes remained in the germline configuration (65) .
We and others have proposed that similarly to the immunoglobulin heavy and light chain genes, rearrangements of the TCR genes may observe a developmental hierarchy during thymic development, that is TCR y and (3 rearrange before TCR a (24, 48, 63, 64) . Although it has been demonstrated that TCR y and 6 are transcribed early in T cell ontogeny (3), the precise order of rearrangements is unknown. In our series of 33 T-ALL, no discordant TCR aand y rearrangements were observed. These results are consistent with previous reports that TCR y and agenes are generally rearranged concordantly in T-ALL (17, 21) . In contrast to T-ALL, discordant rearrangements between TCR 6 and y were frequently observed in lymphoid precursor ALL, the majority of which had undergone recombinations involving the TCR agene while retaining the TCR y gene in the germline configuration. Similar results were reported recently (21, 22) . Based on these findings we propose that the TCR a gene may be rearranged before the TCR y gene very early in lymphoid development. T-ALL may originate from more mature cells that have already undergone both TCR aand y rearrangements. Further studies in nonleukemic precursor cells are necessary to evaluate the question, whether lymphoid precursor leukemias can be used as a paradigm of lymphoid differentiation.
The frequency of TCR a deletions was highest in more mature stages of T cell differentiation. Whereas deletions were seen in 25% ofthe alleles in early thymocytes and in 55% ofthe common thymocytes, all but one TCRa/i3+ leukemias displayed biallelic deletion of the TCR 6 locus. This and two previous instances (17) are consistent with the idea that a functional rearrangement of the TCR a gene may be achieved without deleting noth TCR 6 alleles. Of interest is the fact that many of the cases of leukemias with biallelic deletion of the' TCR 6 constant and joining regions retained the major VA regions (VA 1) in the germline configuration. Thus, the TCR 6 deletional mechanism may be activated without prior attempt to rearrange the major variable region V6 1 (3, 4, 20, 40) .
Types of TCR 6 rearrangements in leukemias. Determination of the diversity of TCR 6 gene would provide useful insight in the overall diversity of the TCR -y/6 heterodimers and possibly lead to a better understanding of the function of this T-cell receptor. In this study we sought to determine whether one ofthe J6 regions was used preferentially. Of 200 evaluable alleles, all either retained J6 1 in the germline configuration or rearranged J61 or deleted the complete TCR 6 locus (constant and joining regions). In six alleles, it was not possible to rule out the rearrangement of a joining region 3' ofJ6 (J62). Similar results were obtained in studies in mouse and human (4, 21, 66, 67) , suggesting that the 3' joining regions J62 and 3 are used infrequently.
Analysis of 51 rearranged alleles with four different restriction enzymes allowed the identification of distinct types of rearrangements. These seem to be nonrandomly used in different types of leukemias. Preferential usage of TCR 'y joining and variable (1 1, 12, 14) and of TCR a joining regions (17) between T-and non-T-ALL have been reported previously. In addition, it was possible to evaluate the hypothesis whether lymphoid precursor ALL represent the least mature cell types and therefore are likely to demonstrate the earliest stages of TCR 6 rearrangements. Specifically, it has been proposed by murine thymocyte studies that V-Db or D6-Db rearrangements may represent the earliest recombinatorial events ofthe TCR 6 locus (4, 15) . Rearrangements that do not delete intervening sequences between J6 1 and D62 have been recently reported to prevail in non-T-ALL (21) . The type 3 TCR 6 rearrangement (Table II) is consistent with a D6-Db2 or Va/6-D62 rearrangement. The second most frequent rearrangement in lymphoid precursor ALL (type 6) is consistent with a joining event not involving Jb1, but most likely rearranging regions 5' of D62. The existence of rearranging regions in addition to the known diversity elements Db1 has also been proposed in the murine TCR 6 locus (15) . The types 3 and 6 rearrangements accounted for 84% ofthe rearrangements in lymphoid precursor ALL and 100% in mixed lineage AL.
Leukemias of the T-lineage are more mature than those involving lymphoid precursors and therefore are more likely to demonstrate more mature and complex rearrangements. In fact, T-ALL differed from lymphoid precursor ALL by the presence of rearrangements representing joining events of JO 1 to upstream regions. 28% of the T-ALL alleles had Jb1 rearrangements compared to 5% of the lymphoid precursor ALL alleles.
The limited number of TCR 6 rearrangements in the present study was remarkable. These data suggest a limited genomic repertoire of the TCR 6 gene, as previously proposed for the murine TCR 6 gene (4, 10, 67, 69) . Analysis of functional TCR y genes reveals that the functional diversity may be limited to only three variable regions (Vy5, Vy8, and Vy9) (14, 30, 68). In TCR 6 limited usage of VA regions has been demonstrated in mouse thymocytes and T-lymphocytes and in a number of T y/6 cell lines (3, 4, 5, 7, 10, (66) (67) (68) (69) . We therefore sought to determine whether additional functional TCR 6 rearrangements exist in humans.
One leukemia, which expresses the Ty/6 receptor (case 33) is ofspecial interest. This leukemia presumably uses a different VA region than cases 29-32 and those of others (5-7, 66, 67) . The negative staining pattern with 6TCS-1 which is considered to detect a variable structure of the V I-J6 1 TCR 6 gene product (28) adds more evidence to the hypothesis that this leukemia expresses a TCR 6 gene product which is different from the VA I-J6 1 gene product, typically seen in the PEER cell line (type 8 rearrangement) (see Addendum). In conclusion, our data suggest that only a small number of VA 
